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1. Introduction 
Glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH), a key enzyme in glycolysis, is composed of 
4 identical subunits. This tetrameric structure is 
required for catalytic activity. Low pH and strong 
denaturants lead to dissociation into monomeric units 
and loss of enzymatic activity [l-3]. Removal of the 
denaturing conditions and separation of incorrectly 
folded aggregates lead to complete recovery of the 
specific enzymatic activity as well as the hydrody- 
namic and spectral properties [4,5]. NAD’ enhances 
the rate of reactivation [ 1,2,6]. The purposes of this 
communication is to give evidence of a low molecular 
thermolabile factor, isolated from human liver which 
inhibits the reactivation in vitro of dissociated glycer- 
aldehyde 3-phosphate dehydrogenase but has no direct 
influence on the catalytic activity of the tetramer. 
2. Experimental 
2.1. Reassociation/reactivation assay 
Rabbit muscle glyceraldehyde 3-phosphate dehy- 
drogenase (Boehringer) was prepared by repeated dial- 
ysis at 4°C against 0.01 M sodium phosphate buffer 
(pH 7.5) containing 1 mM EDTA and 5 mM dithio- 
erythritol (DTE). Dissociation occurred after mixing 
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0.1 ml 0.01 M sodium phosphate buffer (pH 7.5) con- 
taining 10 ,ug GAPDH, 1 mM EDTA and 5 mM DTE, 
with 0.1 ml 0.1 M glycine/H,P04 buffer (pH 2.5) 
which also contained 1 mM EDTA and 5 mM DTE, 
for 10 min at 22°C (final pH 2.8). The material with 
inhibitory properties was dissolved in 0.25 M sodium 
phosphate buffer (pH 7.64) and reactivation (22°C) 
was induced by adding 0.8 ml of this mixture to the 
dissociated enzyme. The pH was thereby adjusted to 
7.5. The effect on the reactivation rate was followed 
by measuring the GAPDH-activity according to [3]. 
The final reaction mixture for activity measurement 
contained 0.23 pg GAPDH/ml, 1 mM D,L-glyceralde- 
hyde 3-phosphate, 1 mM NAD’, 0.01 M NazHAsO+ 
1 mM EDTA and 5 mM DTE in 0.05 M sodium diphos- 
phate buffer (pH 8.5). 
2.2. Isolation of the inhibitor 
(i) Saline perfused deep-frozen liver slices (from 
human organ donors fatally injured in traffic acci- 
dents) (200 g) were thawed at 4”C, cut into small 
pieces and homogenized in 400 ml 0.5 M NaCl with 
a Waring homogenizer. The pH was kept at 2.0 by 
adding HCl. After centrifugation for 60 min at 
2000 X g the floating lipid layer and the sediment 
were discarded. The remaining supernatant was 
brought to a final concentration of 6% trichloroacetic 
acid and centrifuged for 30 min at 2000 X g. The sedi- 
ment was discarded and the supernatant extracted 
with diethyl ether to remove trichloroacetic acid. 
After ultrafiltration of the supernatant through an 
UM 10 Amicon membrane at pH 2 .O, desalting with 
an UM 05 Amicon membrane at pH 8.0 and lyophili- 
zation, 1.2 g crude extract (MI 500-10 000) were 
obtained. 
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(ii) This material was dissolved in 5 ml 0.43 M for- 
mic acid (pH 2.0) and chromatographed on a 
Sephadex G-25 column (100 X 2.5 cm, flow rate 
14 ml/h, solvent 0.43 M HCOOH). The excluded vol- 
ume was lyophilized and 105 mg of a white fluffy 
powder was obtained. It contained the inhibitory 
capacity. This material was devoid of the peptides 
reported [7] to inhibit the reactivation of LDH iso- 
enzymes. 
(iii) This material (102 mg) was dissolved in 6 ml 
0.12 M CHaCOOH (pH 3.0) and ultracentrifuged for 
30 min at 100 000 X g. The supernatant which was 
devoid of the inhibitor was discarded. The sediment 
was dissolved in 0.12 M CH,COOH and lyophilized, 
yielding 22.5 mg white powder containing the mate- 
rial which inhibited the reactivation of GAPDH. 
(iv) This material (16 mg) was chromatographed on 
a Sephadex G-50 column equilibrated with 0.25 M 
sodium phosphate buffer (pH 7.64). The elution pro- 
file is shown in fig.1. 
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Fig.1. Chromatography on a Sephadex G-50 column in 0.25 M 
sodium phosphate buffer (pH 7.64). Column: 85 X 1.5 cm, 
elution rate 14 ml/h with fractions of 3.5 ml. Calibration was 
with: (A) albumin (exclusion volume); (B) cytochrome c 
(Mr 12 500); (C) corticotropin A (Mr 5 300); (D) bacitracin 
(Mr 1460); (E) Thr-Lys-Pro-Arg (Mr 500). Aliquots of the 
effluent were withdrawn and tested for inhibition of GAPDH- 
reactivation. The effect of the inhibitor is expressed in “/o 
recovery of catalytic activity after 18 h reactivation, com- 
pared to a dissociated and reactivated control (o-o). The 
solid line represents the track of the Wdetector at 206 nm. 
(v) The three most active fractions exhibiting -90% 
inhibition (fig.1) were desalted over a Sephadex G-l 5 
column using distilled water. After lyophilization 
100 pg of a white powder was obtained (table 1). 
3. Results and discussion 
3 .l . Effect of the inhibitor on glyceraldehyde 3-phos- 
phate dehydrogenase 
Native tetramers as well as reassociating subunits 
were used as targets of the inhibitor. The inhibitor 
had no immediate effect on the catalytic activity of 
the tetramer. An immediate effect of the inhibitor 
was found when it was exposed to dissociated GAPDH 
before reactivation. This strongly suggests that the 
inhibitor interferes in the folding/association/activa- 
tion of inactive monomers to catalytically active 
tetramers. By using material obtained after the acid 
precipitation and ultracentrifugation a hyperbolic 
dose-response curve is obtained (fig.2). A concentra- 
tion of 200 pg/ml was necessary to achieve half-maxi- 
mal inhibition of the reactivation. By the last isolation 
step on Sephadex G-50 in 0.25 M sodium phosphate 
buffer (pH 7.64) purification of -1 OO-fold was 
achieved (fig.]). However the desalting procedure by 
Sephadex G-l 5 in distilled water resulted in a consid- 
erable loss of specific activity (table 1). 
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Fig.2. Dose-response curve. Inhibitor containing material 
obtained after precipitation with 0.12 M acetic acid was 
tested as described. Reactivation rate was determined after 
18 h and compared with a control without inhibitor. 
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3.2. Summary of the increase of the specific activity 
during the isolation described in section 2.2 
Table 1 
Isolation step 
- 
Starting material 
Yield (mg) Specific activity 
(cont. for 50% 
inhibition) 
200000 - 
(i) Crude extract 1200 Trichloroacetic 
acid contami- 
nated 
(ii) Sephadex G-25 col- 
umnin0.43 M 
HCOOH 
(iii) Acid precipitation 
(iv) Sephadex G-50 col- 
umn in 0.25 M 
phosphate buffer 
(pH 7.64) 
(v) Desalting 
(Sephadex G-15) 
105 900 pg/ml 
22.5 2 10 pg/ml 
-0.1 -2 Ccg/ml 
0.1 200 ccg/ml 
3.3. Characterization of the inhibitor 
As shown in fig.1 the inhibitor emerges from the 
Sephadex G-50 column in 0.25 M sodium phosphate 
buffer (pH 7.64) as a symmetrical peak which corre- 
sponds to -1000-1500 app.M,. However, when 
chromatography was performed in 0.43 M HCOOH 
using Bio-Gel P-2, Sephadex G-25 or Sephadex G-50 
columns most of the inhibitor emerges in the excluded 
volume. This apparent aggregation at low pH was used 
to purify the inhibitor by Sephadex G-25 and ultra- 
centrifugation at pH 2-3. 
Free-flow electrophoresis revealed a negative net 
charge of the inhibitor at pH 6.5. During all purifica- 
tion procedures performed the GAPDH-reactive fac- 
tor was associated with ninhydrin-positive material. 
A slow deactivation occurs at room temperature 
as well as in the cold when the inhibitor was stored in 
0.25 M sodium phosphate buffer (pH 7.64). Moderate 
heating leads to rapid deactivation of the inhibitor 
(fig.3). Oxidation of essential SH-groups of GAPDH 
would also lead to a decreased recovery of enzymatic 
activity [2,5]. To exclude the possibility that the 
reduced recovery of catalytic activity was due to oxi- 
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Fig.3. Time course of reactivation and effect of exposing the 
inhibitor to high temperature. Recovery of GAPDH-activity is 
expressed in % compared to fully associated enzyme: (0) con- 
trol without inhibitor; (o) with 240 pg/ml of inhibitor-con- 
taining material; (0) same experiment but inhibitor exposed 
for 5 min to 60°C prior to the experiment; (A) inhibitor 
exposed for 5 min to 70°C. 
dation by an unspecific SH-group reagent, the inhibi- 
tor was incubated for 3 h at 22°C with 5 mM DTE. 
The properties of the DTE-treated inhibitor were iden 
tical to a control sample which was not DTE-treated. 
4. Conclusions 
In [7], two isoenzyme specific inhibitors of mus- 
cle-type and heart-type lactate dehydrogenase were 
shown. Both inhibitors were peptides with low M,-val- 
ues. They had no effect on the catalytic activity of 
the tetrameric isoenzymes but inhibited the reactiva- 
tion of dissociated subunits. Here, we suggest hat fac- 
tors which affect the folding/association/activation of 
oligomeric enzymes might not be restricted to LDH 
isoenzymes but could represent a part of a general 
mechanism in metabolic regulation. 
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